Sergey A. Dryga, PhD, MBA – Q Biotech Corp. founder and CEO.
Dr. Dryga is a seasoned business leader with strong technical background. He has built several high-performance R&D teams prior to starting Q Biotech Corp. His technical expertise encompasses such diverse areas as viral vectors, vaccine development, protein and nucleic acid purification, nanomaterials, in vitro diagnostics and semiconductor-based biosensor development, his inventions are protected by 34 issued US patents, over 40 applications and numerous international patents. In his role as Chief Scientific Officer and VP of Pilot Manufacturing at NanoDx, Inc. he led instrument, sensor and chemistry development for an in vitro diagnostics system which currently is in pre-clinical evaluation and manufacturing scale up. Sergey has strong experience in leading IP strategy, business development and interaction with investors, customers and other stakeholders, strategic planning and general management.
Dr. Dryga founded Q Biotech Corp in November 2022 to implement and commercialize his patents-pending inventions in automated protein and nucleic acid purification that promise to revolutionize purification methods commonly used in biotechnology research.
Bob Evans Vice President Business Development
Bob has dedicated nearly his entire career to the Life Sciences field. He began by designing and manufacturing histopathology systems, then expanded his expertise to include molecular biology, PCR, vacuum concentrators, centrifuges, and various other laboratory instruments. He transitioned into marketing and business development roles for several large international companies managing North America sales for a Clinical Research Organization.
Bob is originally from Liverpool in the United Kingdom and holds degrees in Mathematics, Electronics and an MBA from Dowling College.